Malaysian Genomics Resource Centre Berhad operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Malaysian Genomics Resource Centre Berhad with three other
pharmaceutical manufacturers in Asia:
Biostar Pharmaceuticals Incorporation
sales of 15.86 million Chinese Renmimbi [US$2.35 million]
of South Korea
(2.50 billion Korean Won [US$2.24 million]
Vista Pharmaceuticals Limited
based in India
(153.80 million Indian Rupees [US$2.39 million]
Malaysian Genomics Resource Centre Berhad reported sales of 10.43 million Malaysian Ringgits (US$2.44 million)
June of 2016.
decrease of 24.9%
versus 2015, when the company's sales were 13.90 million Malaysian Ringgits.